The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

The popular medications may still suffer from local shortages, but FDA is confident that the national supply will remain ...

After quite a crushing bull stampede in 2024, the stock price of weight loss drug star Novo Nordisk (NYSE: NVO) has come down ...

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — ...

Today we'll look at six European stocks that could continue outperforming in 2025. Some of these companies are available to ...